Our innovative therapeutic approach targets upstream amplifiers of disease offering potential treatments across a diverse array of therapeutic indications. Calluna Pharma is a clinical stage biotech company driven by a commitment to improve patient outcomes in diseases where existing treatments are sub-optimal. We believe in the power of immunology to push boundaries, challenge the status quo, and develop therapies that will make a real difference for people living with serious diseases.
| Website | http://www.callunapharma.com/ |
| Employees | 26 (16 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Drug Development, Therapeutic Solutions, Biotech, Clinical Trials, Pharmaceutical Research, Biopharmaceutical, Drug Discovery, Pharmaceutical, Innovative Treatments, Clinical Stage Biotech, Disease Treatment, Medical Research, Patient Care, Health Solutions, Precision Medicine, New Therapies, Healthcare |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences +55 more (view full list) |
Looking for a particular Calluna Pharma employee's phone or email?
Calluna Pharma Questions
Mark Gaffney is the Chief Executive Officer and Board member of Calluna Pharma.
16 people are employed at Calluna Pharma.
Top Calluna Pharma Employees
-
25+
-
Caroline Kurtz
Chief Scientific Officer at Calluna Pharma
Cambridge, MA, US23 -
Anjeza Gjino
Fractional CFO at Calluna Pharma
Boston, MA, US53
